Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Daniel S. Goldberger | Chief Executive Officer | 2023-09-15 | 1,500 | $5.56 | $8.33kBuy |
Thomas J. Errico | Director | 2023-08-02 | 45,607 | $4.35 | $198.39kBuy |
Daniel S. Goldberger | Chief Executive Officer | 2023-08-02 | 50,991 | $4.35 | $221.81kBuy |
F. Peter Cuneo | Director | 2023-08-02 | 5,665 | $4.35 | $24.64kBuy |
Julie Ann Goldstein | Director | 2023-08-02 | 33,994 | $4.35 | $147.87kBuy |
Trevor J. Moody | Director | 2023-08-02 | 22,662 | $4.35 | $98.58kBuy |
Thomas M. Patton | Director | 2023-08-02 | 11,049 | $4.35 | $48.06kBuy |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Joseph P. Errico | 64.34% | 3,861,942 | $23.79M | Insider |
Merck Global Health Innovation Fund LLC | 55.74% | 3,346,032 | $20.61M | Insider |
James L. L. Tullis | 33.55% | 2,014,110 | $12.41M | Insider |
Thomas J. Errico | 14.91% | 894,696 | $5.51M | Insider |
Core Ventures Ii LLC | 10.77% | 646,342 | $3.98M | Insider |
Awm Investment Company Inc | 9.17% | 550,364 | $3.39M | Institution |
Peter S. Staats | 7.94% | 476,419 | $2.93M | Insider |
Charles Steve Theofilos | 7.43% | 446,176 | $2.75M | Insider |
Francis R. Amato | 6.14% | 368,355 | $2.27M | Insider |
Daniel S. Goldberger | 3.52% | 211,060 | $1.30M | Insider |